Sunday, August 5, 2012

Daily News Digest: Reuters Health News Headlines - Yahoo! News

Daily News Alert
Yahoo! Alerts Yahoo! News | My Alerts | Edit Alert
Sunday, August 5, 2012 8:30 PM PDT
Today's Reuters Health News Headlines - Yahoo! News:
Murray win shows psychological power of winning streak
Sun,5 Aug 2012 04:57 PM PDT
Reuters - LONDON (Reuters) - The tale of British tennis player Andy Murray's Wimbledon despair turning to Olympic joy shows the sheer power of the psychological advantage that a supportive home crowd and a gold medal-winning streak by your national team can give. Exactly four weeks after Switzerland's Roger Federer beat him and reduced him to tears on the same Wimbledon centre court, Murray hit back during the London 2012 Olympics on Sunday with a thrashing 6-2 6-1 6-4 win over the world number one. ... Full Story
Top

Red Cross attacked with rockets, grenades in Libya
Sun,5 Aug 2012 04:34 PM PDT
Reuters - GENEVA (Reuters) - Unknown assailants attacked a compound of the International Committee of the Red Cross in the Libyan port of Misrata on Sunday with grenades and rockets, forcing it to suspend its work there and in the eastern city of Benghazi, the agency said. The ICRC said seven of its aid workers were inside their residence when it came under attack. No one was hurt, but damage to the building was extensive. It was the fifth time in less than three months that violence was directed against the independent aid agency in Libya, the ICRC said in a statement, which stressed its neutrality. ... Full Story
Top

Fat? We are fit. Get over it, say women athletes
Sun,5 Aug 2012 01:50 PM PDT
Reuters -

Holley Mangold of the U.S. competes in the women's +75kg group A weightlifting competition at the ExCel venue during the London 2012 Olympic GamesLONDON (Reuters) - American weightlifter Holley Mangold tips the scales at 346 pounds (157 kilograms) and she is proud of being the heaviest woman at the London Olympics. Mangold, 22, who competed in the women's 75 kilogram-plus division, is one of growing number of women athletes speaking out at their frustration with the public scrutiny of their body size and image rather than their fitness and skills. ...


Full Story
Top

Cycling doctor gets chimps, gremlins on track
Sun,5 Aug 2012 08:47 AM PDT
Reuters - LONDON (Reuters) - It used to take world record-breaking cyclist Victoria Pendleton almost an hour and a half to pull herself out of a potentially defeatist mental crisis at crucial international competitions. Now she can do it in five minutes - thanks to the British cycling team's beloved brain trainer Steve Peters. Little wonder, then, that British cycling's poster girl and multiple Olympic gold medalist calls him "the most important person in my career". "I get inside their head and start to perceive their world. ... Full Story
Top

China detains almost 2,000 in fake drug sweep
Sat,4 Aug 2012 08:31 PM PDT
Reuters - BEIJING (Reuters) - Chinese police have detained almost 2,000 people in a nationwide sweep on fake drugs, seizing more than $180 million worth of counterfeit products and destroying some 1,100 production facilities, the public security ministry said on Sunday. The operation, involving around 18,000 police officers, discovered fake or adulterated drugs purporting to deal with illnesses ranging from diabetes to high blood pressure and rabies, the ministry said in a statement on its website (www.mps.gov.cn). ... Full Story
Top

K-V Pharmaceutical files for bankruptcy protection
Sat,4 Aug 2012 12:33 PM PDT
Reuters - CHICAGO (Reuters) - K-V Pharmaceutical, a Bridgeton-Missouri based company focused on women's healthcare products, filed for bankruptcy protection on Saturday, blaming federal actions that kept it from getting "full value" of a drug aimed at preventing premature births. The company, founded in 1942, listed debts of $728.3 million and assets of $236.6 million in a filing in bankruptcy court in New York. ... Full Story
Top

Bayer eyes higher dividend: CFO in paper
Sat,4 Aug 2012 06:26 AM PDT
Reuters -

Bayer CFO Baumann poses during a news conference in LeverkusenFRANKFURT (Reuters) - The finance chief of Bayer, Germany's largest drugmaker, raised the prospect of a dividend increase next year, following a higher profit outlook issued last month. "Our operating business is developing very well at the moment," Chief Financial Officer Werner Baumann told Sunday paper Frankfurter Allgemeine Sonntagszeitung in an interview, according to an excerpt made available to Reuters on Saturday. "Our last dividend was 1.65 euros per share. If adjusted earnings gain 10 percent as planned, we will have leeway for an increase. ...


Full Story
Top

Some Ugandan Ebola patients likely to survive: doctors
Sat,4 Aug 2012 03:51 AM PDT
Reuters -

Handout of de la Rosa, manager of the Ebola Emergency ward, is seen inside the hospital of Kigadi town in the Ugandan Western district of KibaaleKAMPALA (Reuters) - Some of the 32 Ebola patients in isolation at a government hospital in western Uganda's Kibaale district are responding to treatment and may be discharged soon, a health official said on Friday. The east African country has been battling an outbreak of the deadly Ebola virus which has so far killed 16 people. Health officer Dan Kyamanywa said on Friday there had been no new deaths in two days. "There are signs of optimism because a big number of the 32 patients we have in isolation are recovering. ...


Full Story
Top

U.S. to resume beef imports from Japan after two-year ban
Fri,3 Aug 2012 11:36 PM PDT
Reuters - TOKYO (Reuters) - The United States will restart importing beef from Japan this month, ending a two-year suspension imposed after foot-and-mouth disease was found in Japanese cows, the farm ministry in Tokyo said. Imports into the U.S., which were halted in April 2010 after the discovery of Japanese cows infected with the virus, will resume on August 17, Japan's farm ministry said in a statement released on Friday. "The United States (will) resume imports from Japan from August 17 onwards, acknowledging that (Japan) is clean from foot-and-mouth disease," the ministry said. ... Full Story
Top

Pigs under scrutiny at Midwest state fairs after flu outbreak
Fri,3 Aug 2012 04:42 PM PDT
Reuters -

Pigs stick their noses through a gate in the animal pavilion at Green Week Agriculture and Food fair in BerlinCOLUMBUS, Ohio (Reuters) - People flocking to agricultural fairs across the United States were warned on Friday to be cautious around pigs after reports this week of nearly a dozen swine flu cases linked to attendance at fairs where sick pigs were present. Ten new cases of influenza A (H3N2) variant were reported in Ohio and one in Indiana associated with attendance at agricultural fairs. Another case was reported from Hawaii. ...


Full Story
Top

Kids who drink soda may not drop milk
Fri,3 Aug 2012 03:44 PM PDT
Reuters -

Jessie Rodriguez, 8, and his brother Christopher Rodriguez, 3, drink soda as they sit in the shade on a hot day in downtown Los AngelesNEW YORK (Reuters Health) - Kids who drink sugary beverages are not necessarily switching to them and away from milk, according to a new study whose results contradict earlier evidence that sodas and other sweetened drinks are displacing more nutritious ones in kids' diets. Instead, based on surveys of more than 7,000 middle-schoolers, researchers found that some kids may drink less milk as they grow older, but their consumption of soda and other sweetened drinks remains fairly steady. Sugary drink intake did not appear to be rising to replace milk. ...


Full Story
Top

FDA to review Medivation, Astellas' prostate cancer drug in November
Fri,3 Aug 2012 03:36 PM PDT
Reuters -

Logo of Astellas Pharma Inc. is seen at the company's headquarters in Tokyo(Reuters) - Medivation Inc and Japanese partner Astellas Pharma Inc said the U.S. health regulator has set an action date of November 22 to review the companies' marketing application for their experimental prostate cancer drug. Codenamed MDV3100, the drug is designed to treat men with castration-resistant prostate cancer for whom chemotherapy has failed. The U.S. Food and Drug Administration last month granted the drug a priority review, a designation given to expedite the review of treatments that aim to cure serious diseases and fill unmet medical needs. ...


Full Story
Top

FDA approves Sanofi/Regeneron colon cancer drug
Fri,3 Aug 2012 03:19 PM PDT
Reuters -

Logo of French drugmaker Sanofi-Aventis is seen on the facade of their headquarters in Paris(Reuters) - The U.S. Food and Drug Administration said on Friday that it had approved the Sanofi SA and Regeneron Pharmaceuticals Inc drug Zaltrap for patients with metastatic colorectal cancer whose tumors have failed to respond to earlier treatment with chemotherapy. The infused medicine, to be taken in combination with standard chemotherapy, will compete with Roche Holding AG's Avastin and Bristol-Myers Squibb Co's Erbitux. Industry analysts say they expect Zaltrap to win peak annual sales of perhaps $300 million to $400 million, well below the widely used older treatments. ...


Full Story
Top

Thousands to be tested for hepatitis C in New Hampshire
Fri,3 Aug 2012 01:37 PM PDT
Reuters - BOSTON (Reuters) - Thousands of former patients at a New Hampshire hospital have been given permission to be tested to discover whether they were infected with the hepatitis C virus by a medical technician charged with stealing drugs and contaminating needles. The New Hampshire Department of Health and Human Services on Friday announced plans for testing about 3,300 former patients of Exeter Hospital who may have been infected. Any patient treated in the hospital's main operating rooms or intensive care unit between April 1, 2011 and May 25, 2012 may be at risk of infection. ... Full Story
Top

U.S. FDA approves generic versions of Merck's Singulair
Fri,3 Aug 2012 01:13 PM PDT
Reuters -

A sample of the drug SingulairWASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair, the $5 billion-a-year asthma and allergy drug that is Merck & Co Inc's best-selling product. The drugmakers, whose cheaper versions of Singulair are expected to quickly steal two thirds of the branded product's sales, include Mylan Inc, Teva Pharmaceutical Industries Ltd and the Sandoz division of Novartis AG. ...


Full Story
Top



You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.
\"\"

No comments:

Post a Comment